Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11278317rdf:typepubmed:Citationlld:pubmed
pubmed-article:11278317lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:11278317lifeskim:mentionsumls-concept:C0332307lld:lifeskim
pubmed-article:11278317lifeskim:mentionsumls-concept:C0079427lld:lifeskim
pubmed-article:11278317lifeskim:mentionsumls-concept:C0022660lld:lifeskim
pubmed-article:11278317lifeskim:mentionsumls-concept:C0033684lld:lifeskim
pubmed-article:11278317lifeskim:mentionsumls-concept:C1325410lld:lifeskim
pubmed-article:11278317lifeskim:mentionsumls-concept:C1418835lld:lifeskim
pubmed-article:11278317lifeskim:mentionsumls-concept:C0754682lld:lifeskim
pubmed-article:11278317pubmed:issue17lld:pubmed
pubmed-article:11278317pubmed:dateCreated2001-4-24lld:pubmed
pubmed-article:11278317pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11278317pubmed:abstractTextThe INK4a gene, one of the most often disrupted loci in human cancer, encodes two unrelated proteins, p16(INK4a) and p14(ARF) (ARF) both capable of inducing cell cycle arrest. Although it has been clearly demonstrated that ARF inhibits cell cycle via p53 stabilization, very little is known about the involvement of ARF in other cell cycle regulatory pathways, as well as on the mechanisms responsible for activating ARF following oncoproliferative stimuli. In search of factors that might associate with ARF to control its activity or its specificity, we performed a yeast two-hybrid screen. We report here that the human homologue of spinophilin/neurabin II, a regulatory subunit of protein phosphatase 1 catalytic subunit specifically interacts with ARF, both in yeast and in mammalian cells. We also show that ectopic expression of spinophilin/neurabin II inhibits the formation of G418-resistant colonies when transfected into human and mouse cell lines, regardless of p53 and ARF status. Moreover, spinophilin/ARF coexpression in Saos-2 cells, where ARF ectopic expression is ineffective, somehow results in a synergic effect. These data demonstrate a role for spinophilin in cell growth and suggest that ARF and spinophilin could act in partially overlapping pathways.lld:pubmed
pubmed-article:11278317pubmed:languageenglld:pubmed
pubmed-article:11278317pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11278317pubmed:citationSubsetIMlld:pubmed
pubmed-article:11278317pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11278317pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11278317pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11278317pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11278317pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11278317pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11278317pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11278317pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11278317pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11278317pubmed:statusMEDLINElld:pubmed
pubmed-article:11278317pubmed:monthAprlld:pubmed
pubmed-article:11278317pubmed:issn0021-9258lld:pubmed
pubmed-article:11278317pubmed:authorpubmed-author:La MantiaGGlld:pubmed
pubmed-article:11278317pubmed:authorpubmed-author:SansoniBBlld:pubmed
pubmed-article:11278317pubmed:authorpubmed-author:ParisiTTlld:pubmed
pubmed-article:11278317pubmed:authorpubmed-author:BorrelliLLlld:pubmed
pubmed-article:11278317pubmed:authorpubmed-author:CalabròVVlld:pubmed
pubmed-article:11278317pubmed:authorpubmed-author:CalogeroR ARAlld:pubmed
pubmed-article:11278317pubmed:authorpubmed-author:SaviozziSSlld:pubmed
pubmed-article:11278317pubmed:authorpubmed-author:VivoMMlld:pubmed
pubmed-article:11278317pubmed:issnTypePrintlld:pubmed
pubmed-article:11278317pubmed:day27lld:pubmed
pubmed-article:11278317pubmed:volume276lld:pubmed
pubmed-article:11278317pubmed:ownerNLMlld:pubmed
pubmed-article:11278317pubmed:authorsCompleteYlld:pubmed
pubmed-article:11278317pubmed:pagination14161-9lld:pubmed
pubmed-article:11278317pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:11278317pubmed:meshHeadingpubmed-meshheading:11278317...lld:pubmed
pubmed-article:11278317pubmed:meshHeadingpubmed-meshheading:11278317...lld:pubmed
pubmed-article:11278317pubmed:meshHeadingpubmed-meshheading:11278317...lld:pubmed
pubmed-article:11278317pubmed:meshHeadingpubmed-meshheading:11278317...lld:pubmed
pubmed-article:11278317pubmed:meshHeadingpubmed-meshheading:11278317...lld:pubmed
pubmed-article:11278317pubmed:meshHeadingpubmed-meshheading:11278317...lld:pubmed
pubmed-article:11278317pubmed:meshHeadingpubmed-meshheading:11278317...lld:pubmed
pubmed-article:11278317pubmed:meshHeadingpubmed-meshheading:11278317...lld:pubmed
pubmed-article:11278317pubmed:meshHeadingpubmed-meshheading:11278317...lld:pubmed
pubmed-article:11278317pubmed:meshHeadingpubmed-meshheading:11278317...lld:pubmed
pubmed-article:11278317pubmed:meshHeadingpubmed-meshheading:11278317...lld:pubmed
pubmed-article:11278317pubmed:meshHeadingpubmed-meshheading:11278317...lld:pubmed
pubmed-article:11278317pubmed:meshHeadingpubmed-meshheading:11278317...lld:pubmed
pubmed-article:11278317pubmed:meshHeadingpubmed-meshheading:11278317...lld:pubmed
pubmed-article:11278317pubmed:meshHeadingpubmed-meshheading:11278317...lld:pubmed
pubmed-article:11278317pubmed:meshHeadingpubmed-meshheading:11278317...lld:pubmed
pubmed-article:11278317pubmed:meshHeadingpubmed-meshheading:11278317...lld:pubmed
pubmed-article:11278317pubmed:meshHeadingpubmed-meshheading:11278317...lld:pubmed
pubmed-article:11278317pubmed:meshHeadingpubmed-meshheading:11278317...lld:pubmed
pubmed-article:11278317pubmed:meshHeadingpubmed-meshheading:11278317...lld:pubmed
pubmed-article:11278317pubmed:meshHeadingpubmed-meshheading:11278317...lld:pubmed
pubmed-article:11278317pubmed:meshHeadingpubmed-meshheading:11278317...lld:pubmed
pubmed-article:11278317pubmed:meshHeadingpubmed-meshheading:11278317...lld:pubmed
pubmed-article:11278317pubmed:meshHeadingpubmed-meshheading:11278317...lld:pubmed
pubmed-article:11278317pubmed:meshHeadingpubmed-meshheading:11278317...lld:pubmed
pubmed-article:11278317pubmed:meshHeadingpubmed-meshheading:11278317...lld:pubmed
pubmed-article:11278317pubmed:meshHeadingpubmed-meshheading:11278317...lld:pubmed
pubmed-article:11278317pubmed:meshHeadingpubmed-meshheading:11278317...lld:pubmed
pubmed-article:11278317pubmed:meshHeadingpubmed-meshheading:11278317...lld:pubmed
pubmed-article:11278317pubmed:meshHeadingpubmed-meshheading:11278317...lld:pubmed
pubmed-article:11278317pubmed:meshHeadingpubmed-meshheading:11278317...lld:pubmed
pubmed-article:11278317pubmed:year2001lld:pubmed
pubmed-article:11278317pubmed:articleTitleThe human tumor suppressor arf interacts with spinophilin/neurabin II, a type 1 protein-phosphatase-binding protein.lld:pubmed
pubmed-article:11278317pubmed:affiliationDepartment of Genetics, General and Molecular Biology, University of Naples "Federico II," via Mezzocannone 8, Napoli 80134, Italy.lld:pubmed
pubmed-article:11278317pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11278317pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:1029entrezgene:pubmedpubmed-article:11278317lld:entrezgene
entrez-gene:84687entrezgene:pubmedpubmed-article:11278317lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:11278317lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11278317lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11278317lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11278317lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11278317lld:pubmed